Proteogenomics

"Proteogenomics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
The systematic study of annotated genomic information to global protein expression in order to determine the relationship between genomic sequences and both expressed proteins and predicted protein sequences.


expand / collapse Publications
This graph shows the total number of publications written about "Proteogenomics" by people in this website by year, and whether "Proteogenomics" was a major or minor topic of these publications.
Below are the most recent publications written about "Proteogenomics" by people in Profiles.
  1. Large-scale proteogenomics characterization of microproteins in Mycobacterium tuberculosis. Sci Rep. 2024 12 28; 14(1):31186.
    View in: PubMed
  2. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma. Cancer Cell. 2024 Nov 11; 42(11):1970-1982.e7.
    View in: PubMed
  3. Proteogenomic analysis integrated with electronic health records data reveals disease-associated variants in Black Americans. J Clin Invest. 2024 Sep 24; 134(21).
    View in: PubMed
  4. The Proteogenomics of Prostate Cancer Radioresistance. Cancer Res Commun. 2024 09 01; 4(9):2463-2479.
    View in: PubMed
  5. Rp3: Ribosome profiling-assisted proteogenomics improves coverage and confidence during microprotein discovery. Nat Commun. 2024 Aug 09; 15(1):6839.
    View in: PubMed
  6. Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis. Circulation. 2024 02 27; 149(9):669-683.
    View in: PubMed
  7. Multi-tissue proteogenomic analysis for mechanistic toxicology studies in non-model species. Environ Int. 2023 Dec; 182:108309.
    View in: PubMed
  8. Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ. Nat Commun. 2023 09 13; 14(1):5670.
    View in: PubMed
  9. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell. 2023 08 03; 186(16):3476-3498.e35.
    View in: PubMed
  10. Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways. Elife. 2022 09 21; 11.
    View in: PubMed